Our Pricing

Understanding Burps On Mounjaro: Side Effects Explained

Published on: June 03, 2026

If you're experiencing burps on mounjaro uk treatment, you're not alone—burping and belching affect up to 30% of patients starting tirzepatide therapy. At Cured Pharmacy, our UK clinical team helps patients understand and manage this common gastrointestinal side effect whilst continuing their weight loss journey safely.

Why Does Mounjaro Cause Burping and Belching?

Mounjaro (tirzepatide) causes burping through its primary mechanism of action as a dual GIP/GLP-1 receptor agonist [1]. By slowing gastric emptying—the rate at which food leaves your stomach—tirzepatide increases the time food remains in the digestive tract, which can lead to increased gas production and subsequent burping.

This delayed gastric emptying is actually a therapeutic benefit, contributing to the appetite suppression and significant weight loss seen in clinical trials [1]. However, the trade-off for many patients is temporary digestive discomfort including burping, bloating, and occasional sulphur-tasting belches caused by hydrogen sulphide gas production during slower digestion.

The SURPASS-1 trial reported gastrointestinal adverse events in 20-35% of patients on tirzepatide, with burping and eructation being among the most commonly reported symptoms during the initial 8-12 weeks of treatment [2]. These symptoms typically diminish as your body adjusts to the medication.

Sulphur Burps on Mounjaro: What Causes the Smell?

Sulphur burps—characterised by a distinctive rotten egg smell—occur when bacteria in your digestive system break down sulphur-containing proteins more slowly due to Mounjaro's effect on gastric motility. The resulting hydrogen sulphide gas travels back up the oesophagus, creating that unpleasant odour.

Foods high in sulphur compounds can exacerbate this side effect. Common culprits include eggs, red meat, dairy products, cruciferous vegetables (broccoli, cauliflower, Brussels sprouts), garlic, and onions. Reducing these foods during your initial weeks on Mounjaro may help minimise sulphur burps.

Our superintendent pharmacist Tarun Kumar notes that whilst sulphur burps are unpleasant, they're not medically concerning and usually resolve within 4-8 weeks as your digestive system adapts to the medication. If symptoms persist beyond 12 weeks or worsen significantly, contact your prescriber for review.

How Long Do Burps on Mounjaro Last?

Timeline of Digestive Side Effects

Most patients experience burping most intensely during the first 2-4 weeks after starting Mounjaro or after dose increases. Clinical data from the SURPASS trials shows that gastrointestinal side effects typically peak within the first month and gradually diminish over 8-12 weeks as tolerance develops [2].

Each time you increase your Mounjaro dose (from 2.5mg to 5mg, 5mg to 7.5mg, etc.), you may experience a temporary return of burping and other digestive symptoms. This is normal and expected—your body needs time to adjust to each new dose level.

Proven Strategies to Reduce Burping on Mounjaro

Dietary Modifications

Eat smaller, more frequent meals rather than three large meals daily. This reduces the volume of food in your stomach at any given time, minimising gas production and burping. Aim for 5-6 small meals spaced evenly throughout the day.

Avoid carbonated beverages, which introduce additional gas into your digestive system. Choose still water, herbal teas, or diluted fruit juices instead. Drinking through straws can also increase air swallowing, so sip directly from a glass.

Reduce high-fat foods, as these take longer to digest and can worsen the delayed gastric emptying effect. Focus on lean proteins, whole grains, and easily digestible vegetables during your initial weeks on treatment.

When to Contact Your UK Prescriber About Burping

Warning Signs Requiring Medical Review

Whilst burping is a common and generally benign side effect, certain symptoms warrant immediate medical attention. Contact your prescriber if you experience persistent vomiting alongside burping, severe abdominal pain, inability to keep liquids down for more than 24 hours, or signs of dehydration such as dark urine or dizziness.

If burping is accompanied by acid reflux symptoms—burning chest pain, regurgitation of food, or difficulty swallowing—your prescriber may recommend additional medications or dose adjustments. Never discontinue Mounjaro without consulting your healthcare provider, as sudden cessation can affect your treatment outcomes.

Burps on Mounjaro UK: Alternative Weight Loss Treatments

If digestive side effects including burping remain intolerable despite management strategies, alternative weight loss treatments are available through Cured Pharmacy. Wegovy (semaglutide) is another GLP-1 receptor agonist that may cause fewer gastrointestinal symptoms in some patients, though individual responses vary [3].

For patients who prefer to avoid injectable medications altogether, oral treatments like Orlistat work through a different mechanism—blocking fat absorption in the intestine—and don't cause the same gastric emptying effects as GLP-1 medications. However, Orlistat carries its own distinct side effect profile related to fat malabsorption.

All prescription weight loss medications available at Cured Pharmacy require an online clinical assessment by a UK prescriber. Our team will review your medical history, current symptoms, and treatment goals to recommend the most appropriate option. Start your free consultation to discuss alternatives if Mounjaro's side effects are impacting your quality of life.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Rosenstock, J., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143–155. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
3. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro is a prescription-only medicine and must be prescribed by a UK-registered clinician following an online consultation. Side effects vary between individuals—contact your prescriber if you experience persistent or severe symptoms.